MiR-22 regulates HIF-1A pathway and tumor progression and represents a possible biomarker of sorafenib response in hepatocellular carcinoma

Saved in:
Bibliographic Details
Published inDigestive and liver disease Vol. 56; pp. S96 - S97
Main Authors Galvani, G., Leoni, I., Monti, E., Vianello, C., Marinelli, S., Marisi, G., Gardini, A. Casadei, Foschi, G.F., Giovannini, C., Baldassarre, M., Ravaioli, M., Cescon, M., Vasuri, F., Domenicali, M., Negrini, M., Piscaglia, F., Stefanelli, C., Gramantieri, L., Fornari, F.
Format Journal Article
LanguageEnglish
Published 01.02.2024
Online AccessGet full text

Cover

More Information
ISSN:1590-8658
DOI:10.1016/j.dld.2024.01.170